Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Avantium N.V. is a leading renewable chemistry technology company specializing in bio-based polymers and sustainable materials. Incorporated as a publicly limited liability company under Dutch law with its headquarters in Amsterdam, it pioneers the transition from fossil-based to renewable plastics using plant-based feedstocks. Its core YXY® technology catalytically converts sugars into FDCA (furandicarboxylic acid), the key building block for PEF (polyethylene furanoate), marketed as the brand Releaf®, a 100% plant-based, fully recyclable polymer offering superior barrier properties and performance compared to traditional PET. Avantium operates state-of-the-art R&D labs in Amsterdam, pilot plants in Geleen and Delfzijl, and opened its FDCA Flagship Plant in Delfzijl in 2024, marking the world's first commercial-scale production of this sustainable chemical. The company also provides advanced catalyst testing services and develops technologies like PlantMEG and CO2-to-chemicals processes, targeting high-value markets in packaging, textiles, films, and molding exceeding €200 billion. With over 300 professionals, a robust IP portfolio of more than 175 patent families, and strategic partnerships, Avantium drives de-fossilization of the chemical industry, fostering a circular economy through innovation, licensing, and commercialization.
The business is unprofitable at the operating level (-294.89% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 30.6% YoY. Margins deteriorated 111.8pp alongside, both lines moving the wrong way.
Negative free cash flow of -€48M. The business is consuming cash, not generating it. Operating margin contracted 111.8pp YoY, cost discipline may be slipping.
Profitability & Returns
Revenue (TTM)
€15M
▼ -30.6% YoY
Net Income (TTM)
-€27M
▲ +16.8% YoY
Op. Margin
-294.89%
▼ -111.8pp YoY
ROIC
-12.51%
▲ +2.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-€48M
▲ +48.9% YoY
Op. Cash Flow (TTM)
-€19M
▲ +37.9% YoY
Net Debt
€99M
Cash & Equiv.
€56M
3Y CAGR: -6.5%
Continue Research